Get the Stockscreener App
3.97
2.70%
-0.11
After Hours:
3.97
Nutriband Inc stock is traded at $3.97, with a volume of 14,167.
It is down -2.70% in the last 24 hours and up +6.43% over the past month.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
See More
Previous Close:
$4.08
Open:
$4.09
24h Volume:
14,167
Relative Volume:
1.29
Market Cap:
$48.26M
Revenue:
$2.28M
Net Income/Loss:
$-12.78M
P/E Ratio:
-1.2945
EPS:
-3.0669
Net Cash Flow:
$-5.65M
1W Performance:
+4.75%
1M Performance:
+6.43%
6M Performance:
-28.21%
1Y Performance:
-34.05%
1-Day Range:
$3.93
$4.1799
1-Week Range:
$3.64
$4.1799
52-Week Range:
$3.42
$11.68
Nutriband Inc Stock (NTRB) Company Profile
Name
Nutriband Inc
Sector
Industry
Phone
407 377-6695
Address
121 S. ORANGE AVE., ORLANDO
Compare NTRB vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
3.97 | 49.60M | 2.28M | -12.78M | -5.65M | -3.0669 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-25 | Initiated | Noble Capital Markets | Outperform |
Nutriband Inc Stock (NTRB) Latest News
Nutriband Inc. Develops FDA-Targeted AVERSA™ Abuse Deterrent Transdermal Patch Technology for Opioid and Stimulant Drugs - Minichart
What naked margin Nutriband (NTRB)? (Risk Aversion) 2026-04-29Trending Social Stocks - Newser
[10-K] NutriBand Inc. Files Annual Report - Stock Titan
NutriBand 10-K: Revenue $2.04M, EPS (2.58) for year ended Jan 31, 2026 - TradingView
Nutriband Inc. Reports Earnings Results for the Full Year Ended January 31, 2026 - marketscreener.com
NTRB Nutriband posts far narrower Q1 2026 loss than analyst projections, shares edge higher on positive investor sentiment.Stability Report - Newser
Nutriband Inc expected to post a loss of $1.89 a shareEarnings Preview - TradingView
Nutriband (NASDAQ: NTRB) CEO Highlights AVERSA Technology on Jack Neel Podcast - Barchart.com
NTRBW Nutriband releases no quarterly earnings metrics, leaving investors awaiting clarity on near-term core business growth trajectory.Social Trading Insights - UBND thành phố Hải Phòng
Is Nutriband (NTRB) stock undervalued by investors | Q1 2026: Earnings Beat EstimatesInvestment Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
NTRB (Nutriband Inc.) Q1 2026 results far outperform loss estimates, post mild revenue gains as shares rise modestly.High Volatility - UBND thành phố Hải Phòng
NTRB Nutriband Q1 2026 earnings beat estimates by wide margin, shares post modest daily gains.AI Stock Signals - Cổng thông tin điện tử tỉnh Lào Cai
Nutriband CEO Discusses AVERSA Technology's Role in Addressing Opioid Crisis on Podcast - citybuzz -
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl - GlobeNewswire
Nutriband (NTRB) to Release Quarterly Earnings on Monday - MarketBeat
NTRB Nutriband posts far better than expected Q1 2026 EPS, yet shares dip slightly on modest year-over-year revenue growth.Hot Momentum Watchlist - Newser
US Market Wrap: Does Nutriband Inc have a competitive edge2026 Action & Real-Time Sentiment Analysis - baoquankhu1.vn
Can Nutriband Inc disrupt its industryQuarterly Performance Summary & Weekly Momentum Stock Picks - baoquankhu1.vn
Aug Outlook: Is Nutriband Inc vulnerable to short sellers2026 Rallies & Capital Protection Trading Alerts - baoquankhu1.vn
Meme Stocks: Does Nutriband Inc have a competitive edge2026 Pullback Review & Reliable Trade Execution Plans - baoquankhu1.vn
Is now the right time to enter Nutriband IncPortfolio Risk Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Nutriband Selects Commercial Brand Name for Abuse-Deterrent Fentanyl Patch Using AVERSA Technology - Minichart
Nutriband Advances Lead Abuse-Deterrent Fentanyl Patch Branding - TipRanks
Abuse-deterrent fentanyl patch at Nutriband (NASDAQ: NTRB) targets $80M-$200M - Stock Titan
Street Watch: Is Nutriband Inc forming bullish engulfing patterns2026 Fundamental Recap & Community Verified Trade Alerts - baoquankhu1.vn
Is Nutriband Inc a good stock for dollar cost averaging2026 Earnings & Intraday High Probability Setup Alerts - baoquankhu1.vn
Is Nutriband (NTRB) Stock Lagging the Market | Price at $3.73, Down 1.36%Low Volatility Stocks - Newser
NTRB Should I Buy - Intellectia AI
Will Nutriband Inc benefit from rising consumer demand2026 Price Swings & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Nutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue Estimates - MSN
Nutriband (NASDAQ: NTRB) Selects Global Brand Name Candidate for AVERSA(TM) Fentanyl Patch - The Globe and Mail
Layoff Watch: Is Nutriband Inc Equity Warrant stock good for income investors2026 Biggest Moves & High Conviction Trade Alerts - baoquankhu1.vn
Institution Moves: Does Nutriband Inc Equity Warrant have pricing power2026 Earnings Impact & AI Forecasted Entry/Exit Points - baoquankhu1.vn
NTRB Technical Analysis & Stock Price Forecast - Intellectia AI
Nutriband Selects Global Brand Name for Abuse-Deterrent Fentanyl Patch - citybuzz -
Investment Recap: Can Nutriband Inc keep up with sector leaders2026 Market Trends & Low Risk Growth Stock Ideas - baoquankhu1.vn
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch - The Manila Times
Nutriband Inc. Announces Aversa as Commercial Name for Abuse-Deterrent Fentanyl Patch - geneonline.com
Nutriband selects brand name for fentanyl patch, submits to FDA - Investing.com
Nutriband selects brand name for fentanyl patch, submits to FDA By Investing.com - Investing.com India
Nutriband seeks FDA review for fentanyl patch designed to deter abuse - Stock Titan
Nutriband divests Pocono stake to fund AVERSA fentanyl - MSN
Bank Watch: Is Nutriband Inc vulnerable to short sellers2026 Institutional & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Layoff Watch: Can Nutriband Inc disrupt its industryProduct Launch & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Nutriband (NASDAQ: NTRB) Secures Costa Rica Approval for Kinesiology Tape Line - Digital Journal
Nutriband receives Costa Rica approval for kinesiology tapes By Investing.com - Investing.com India
Nutriband (NTRB) Gains Approval for Kinesiology Tapes in Costa R - gurufocus.com
Nutriband receives Costa Rica approval for kinesiology tapes - Investing.com
Nutriband Ai Kinesiology Tapes Approved For Distribution And Sale In Costa Rica - TradingView
Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica - The Manila Times
Nutriband Inc Stock (NTRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):